Anthrax Immune Globulin: Phase I/II started

Emergent BioSolutions began a double-blind, dose-escalation, U.S. Phase I/II trial to compare 3 dose levels of a single IV infusion of AIG vs. Gamunex immune globulin from Talecris Biotherapeutics I...